Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant Pfs25

Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant Pfs25

Bibliographic Details
Main Authors:	David C. Kaslow, Ivan C. Bathurst, Stuart N. Isaacs, David B. Keister, Bernard Moss, Philip J. Barr
Format:	Article
Language:	English
Published:	Fundação Oswaldo Cruz (FIOCRUZ) 1992-01-01
Series:	Memorias do Instituto Oswaldo Cruz
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761992000700028

Similar Items

Production and characterisation of the first human monoclonal antibodies against Plasmodium falciparum transmission blocking antigen Pfs25
by: Zaric, M, et al.
Published: (2019)

Antibodies to plant-produced Plasmodium falciparum sexual stage protein Pfs25 exhibit transmission blocking activity.
by: Farrance, C, et al.
Published: (2011)

Antibodies to plant-produced Plasmodium falciparum sexual stage protein Pfs25 exhibit transmission blocking activity
by: Farrance, C, et al.
Published: (2011)

Structural and immunological differences in Plasmodium falciparum sexual stage transmission-blocking vaccines comprised of Pfs25-EPA nanoparticles
by: Nicholas J. MacDonald, et al.
Published: (2023-04-01)

Global diversity of the gene encoding the Pfs25 protein—a Plasmodium falciparum transmission-blocking vaccine candidate
by: Pornpawee Sookpongthai, et al.
Published: (2021-11-01)

Pfs230 and Pfs48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against Plasmodium falciparum
by: Susheel K. Singh, et al.
Published: (2019-06-01)

New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission
by: Kathleen A. McGuire, et al.
Published: (2017-06-01)

Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer
by: Long Carole A, et al.
Published: (2007-08-01)

Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults.
by: Kawsar R Talaat, et al.
Published: (2016-01-01)

mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum
by: Clifford T. H. Hayashi, et al.
Published: (2022-12-01)

A plant-produced Pfs25 VLP malaria vaccine candidate induces persistent transmission blocking antibodies against Plasmodium falciparum in immunized mice.
by: R Mark Jones, et al.
Published: (2013-01-01)

Gametocyte carriage of Plasmodium falciparum (pfs25) and Plasmodium vivax (pvs25) during mass screening and treatment in West Timor, Indonesia: a longitudinal prospective study
by: Kosasih, A, et al.
Published: (2021)

A Reproducible and Scalable Process for Manufacturing a Pfs48/45 Based Plasmodium falciparum Transmission-Blocking Vaccine
by: Susheel K. Singh, et al.
Published: (2021-01-01)

Risk factors for patent and sub-patent gametocyte carriage of Plasmodium falciparum (pfs25) and Plasmodium vivax (pvs25) in hypo- to meso-endemic West Timor in Eastern Indonesia
by: Kosasih, AA, et al.
Published: (2019)

Poor CD4+ T Cell Immunogenicity Limits Humoral Immunity to P. falciparum Transmission-Blocking Candidate Pfs25 in Humans
by: Marija Zaric, et al.
Published: (2021-09-01)

Author Correction: mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum
by: Clifford T. H. Hayashi, et al.
Published: (2023-08-01)

Development and Qualification of an Antigen Integrity Assay for a <i>Plasmodium falciparum</i> Malaria Transmission Blocking Vaccine Candidate, Pfs230
by: Kazutoyo Miura, et al.
Published: (2022-09-01)

Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages
by: Wei-Chiao Huang, et al.
Published: (2022-08-01)

The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania.
by: Teun Bousema, et al.
Published: (2010-11-01)

Structural analysis of Plasmodium falciparum ookinete surface antigen Pfs28 relevant for malaria vaccine design
by: Niharika Shukla, et al.
Published: (2022-11-01)

mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response
by: Puthupparampil V. Scaria, et al.
Published: (2024-01-01)

Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine
by: Susheel K. Singh, et al.
Published: (2021-10-01)

Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25
by: Stephen W. Scally, et al.
Published: (2017-11-01)

Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.
by: Yimin Wu, et al.
Published: (2008-07-01)

Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose
by: Wei-Chiao Huang, et al.
Published: (2020-08-01)

Preclinical evaluations of Pfs25-EPA and Pfs230D1-EPA in AS01 for a vaccine to reduce malaria transmission
by: Kelly M. Rausch, et al.
Published: (2023-07-01)

The Pfs230 N-terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission-blocking vaccine candidate
by: Shwu-Maan Lee, et al.
Published: (2019-11-01)

Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology.
by: Li, Y, et al.
Published: (2016)

Signatures of selection and drivers for novel mutation on transmission-blocking vaccine candidate Pfs25 gene in western Kenya.
by: Kevin O Ochwedo, et al.
Published: (2022-01-01)

Recombination hotspots and population structure in Plasmodium falciparum.
by: Mu, J, et al.
Published: (2005)

Recombination hotspots and population structure in Plasmodium falciparum.
by: Mu, J, et al.
Published: (2005)

Recombination hotspots and population structure in Plasmodium falciparum.
by: Jianbing Mu, et al.
Published: (2005-10-01)

Molecular Analysis of Pfs47-Mediated Plasmodium Evasion of Mosquito Immunity.
by: Gaspar E Canepa, et al.
Published: (2016-01-01)

Evaluation of the Pfs25-IMX313/Matrix-M malaria transmission-blocking candidate vaccine in endemic settings
by: Charles Mulamba, et al.
Published: (2022-06-01)

Transmission blocking immunity as observed in a feeder system and serological reactivity to Pfs 48/45 and Pfs230 in field sera
by: W. Roeffen, et al.
Published: (1994-01-01)

Genetic diversity and population structure of the human malaria parasite Plasmodium falciparum surface protein Pfs47 in isolates from the lowlands in Western Kenya.
by: Shirley A Onyango, et al.
Published: (2021-01-01)

Meiotic recombination, cross-reactivity, and persistence in Plasmodium falciparum.
by: McKenzie, F, et al.
Published: (2001)

Algae-produced Pfs25 elicits antibodies that inhibit malaria transmission.
by: James A Gregory, et al.
Published: (2012-01-01)

Var gene diversity in Plasmodium falciparum is generated by frequent recombination events.
by: Taylor, H, et al.
Published: (2000)

Viral vectored transmission blocking vaccines against <it>Plasmodium falciparum</it>
by: Sinden Robert E, et al.
Published: (2010-10-01)